# PET Imaging of Noradrenergic Transmission in the Brain

> **NCT07686393** · PHASE1 · RECRUITING · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 40 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** 11C-ARMI

## Key facts

- **NCT ID:** NCT07686393
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-14
- **Primary completion:** 2029-02-05
- **Final completion:** 2030-02-20
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07686393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07686393, "PET Imaging of Noradrenergic Transmission in the Brain". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07686393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*